Innovative imaging solutions
AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide. The NanoMslide technology can be universally applied to enhance optical imaging using our, patented, specially coated microscope slides that instantly generate colourised images providing the user with both sample composition and morphology information. The technology fits seamlessly into current workflows and works with any microscopy setup.
Contact UsA quantum leap in imaging
NanoMslide enables any optical microscope to be transformed into a powerful new tool for instant, labelfree, stain-free tissue imaging. By manipulating the interaction of light with tissues at the nanoscale it removes the need for any chemicals, specialised equipment or training.
NanoMslide technology
- reduces time to diagnosis
- is compatible with any standard optical microscope
- provides high-contrast, full-colour imaging without using any chemicals
- has the potential for higher efficacy digital pathology
High-contrast full-colour imaging
.png)
.png)
AlleSense technology provides maximum versatility
Digital Pathology
The global digital pathology market size was valued at USD 882.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2028. NanoMslide offers improved differentiation of abnormalities using digital pathology
Manufacture
NanoMslide can be fabricated reliably, at scale, with no significant variation in quality of output at a highly competitive price point
Instant Detection
The colour contrast feature means easier and quicker identification of abnormal cells. It can be applied to any tissue and is particularly relevant for early diagnosis and difficult to diagnose cancers or for intraoperative applications
The AlleSense Team
Brian is an NHMRC Leadership Fellow at La Trobe University. He has led a number of breakthroughs in the field of optics, been recognised with several national prizes for research excellence and innovation, and had his work published in Nature, Nature Physics, and Nature Photonics
Eugeniu is a Research Fellow in the ARC Centre of Excellence in Advanced Molecular Imaging (AMI) where he manages the Nanofabrication node. Eugeniu is responsible for the the fabrication of plasmonic devices for molecular sensing, including the NanoMslide
Belinda co-Heads the Cancer Evolution and Metastasis Program, and leads the Microenvironmental Crosstalk and Therapeutics laboratory at the Peter MacCallum Cancer Centre in Melbourne. Belinda's team has a particular interest in biomarkers for early-stage breast cancer
Sandra is a Senior Pathologist at Royal Prince Alfred Hospital, Clinical Professor at the University of Sydney, and Senior Research Pathologist at the Garvan Institute. Sandra is also a member of MSAC, which appraises new medical services proposed for public funding in Australia
Julian Sutton brings +25 years global experience in asset management, investment banking and venture capital. He has worked closely with earlystage medical technology companies and is a non-executive director at 4DMedical (ASX:4DX) and VitalTrace
Dr Fisher has +20 years of experience in executive management and leadership positions in higher education and research-based organisations. She has worked closely with companies to commercialise innovative technology through to public listings
AlleSense is a spin out company from La Trobe University
AlleSense are proudly partnered with
For Industry Partners
We are looking to engage with organisations in the health, medical imaging and microscopy sector. If your organisation is interested in working with us on this technology, please contact us.
Contact Us